UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Integra Lifesciences Corporation
(Name of Issuer)
Common Stock, par value $.01 per share
(Title of Class of Securities)
457985 10 9
(CUSIP Number)
______________________
Check the following box if a fee is being paid with this statement /x/. (A
fee is not required only if the filing person: (1) has a previous statement
on file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
_____________________________________________
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Union Carbide Corporation, 13-1421730
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) \ \
(b) \ \
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF 5 SOLE VOTING POWER 3,150,561
SHARES 6 SHARED VOTING POWER None
BENEFICALLY 7 SOLE DISPOSITIVE POWER 3,150,561
OWNED 8 SHARED DISPOSITIVE POWER None
BY EACH
PERSON WITH 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
3,150,561
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW \ \
(9) EXCLUDES CERTAIN SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
13.41%
12 TYPE OF REPORTING PERSON*
CO
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Item 1 (a) Name of Issuer
Integra Lifesciences Corporation
(b) Address of Issuer's Principal Executive Offices
105 Morgan Lane, Plainsboro, NJ 08536
Item 2 (a) Name of Person Filing
Union Carbide Corporation
(b) Address of Principal Business Office or, if none, Residence
30 Old Ridgebury Road
Danbury, CT 06817-0001
(c) Citizenship
Not applicable
(d) Title of Class of Securities
Common Stock, par value $.01 per share.
(e) CUSIP Number
457985 10 9
Item 3 If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b),
check whether the person filing is a: Not applicable
Item 4 Ownership
(a) Amount Beneficially Owned
3,150,561
(b) Percent of Class
13.41%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 3,150,561
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition of:
3,150,561
(iv) shared power to dispose or to direct the disposition of:
None
Item 5 Ownership of Five Percent or Less of a Class
Not applicable.
Item 6 Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7 Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company
Not applicable.
Item 8 Identification and Classification of Members of the Group
Not applicable.
Item 9 Notice of Dissolution of Group
Not applicable.
Item 10 Certification
By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired in the ordinary course of business
and were not acquired by the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in any transaction
having such purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Schedule 13G in connection
with Union Carbide Corporation's beneficial ownership of the common stock of
Integra Lifesciences Corporation at December 31, 1995 is true, complete and
correct.
Dated: February 1, 1996
By /s/John MacDonald
__________________________________________
John MacDonald, Assistant Secretary